miR Scientific is a precision molecular diagnostics company that specializes in non-invasive liquid biopsy testing for cancer detection and management. With a strong focus on urological cancers, the company offers cutting-edge molecular and genomic testing solutions that aim to improve early cancer detection and patient outcomes. miR Scientific uses proprietary RNA-based technology to analyze small non-coding RNA (sncRNA) from urinary exosomes, providing highly accurate insights into cancer presence, progression, and risk stratification. Their testing solutions enable healthcare providers to make more informed decisions, reducing the need for invasive procedures like biopsies. Committed to advancing oncology diagnostics, miR Scientific collaborates with leading institutions to bring innovative, research-driven solutions to the clinical laboratory space.
Key Services:
– Non-invasive molecular diagnostics for cancer detection
– RNA-based liquid biopsy testing
– Urological cancer screenings and risk assessment
– Cancer progression and stratification analysis
– Genomic and precision medicine solutions
